Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

Stopped early

Conditions studied: Primary Myelofibrosis, Primary Pulmonary Hypertension, Secondary Myelofibrosis, Pulmonary Arterial Hypertension

In brief

To determine the prevalence of myelofibrosis in patients with primary pulmonary hypertension, and to discover if the fibrosis in these patients is primary (AMM) or secondary.

Key facts

Study ID

NCT00722254

Run by

University of Utah

People needed

15

Starts

2006-06-01

Expected to finish

2009-02-01

Last updated by the study team

2016-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years of age
• Signed Informed Consent
• Subjects diagnosed with Primary Pulmonary Hypertension or Myelofibrosis (primary or secondary)

You may not qualify if…

• Anyone not meeting the above inclusion criteria
• Pregnant women

Where it is running

• University of Utah — Salt Lake City, Utah, United States
• VA Salt Lake City Health Care System — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.